Melatonin Offers Dual-Phase Protection to Brain Vessel Endothelial Cells in Prolonged Cerebral Ischemia-Recanalization Through Ameliorating ER Stress and Resolving Refractory Stress Granule

• Published in: Translational stroke research Vol. 14; no. 6; pp. 910 - 928
• Main Authors: Lu, Danli, Liu, Yuxin, Huang, Huipeng, Hu, Mengyan, Li, Tiemei, Wang, Shisi, Shen, Shishi, Wu, Ruizhen, Cai, Wei, Lu, Tingting, Lu, Zhengqi
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.12.2023; Springer Nature B.V
• Subjects: Animals; Biomedical and Life Sciences; Biomedicine; Blood vessels; Brain - metabolism; Brain Ischemia - drug therapy; Brain Ischemia - metabolism; Cardiology; Cell culture; Cell death; Cerebral Infarction; Edema; Endothelial Cells - metabolism; Endothelium; Ischemia; Ischemic Stroke; Melatonin; Melatonin - pharmacology; Melatonin - therapeutic use; Mice; Neurology; Neurosciences; Neurosurgery; Permeability; Proteins; Stress Granules; Stroke; Stroke - drug therapy; Stroke - metabolism; Vascular Surgery; Veins & arteries; Caspase-7; Melatonin; Stroke; ER stress; Stress granules; Autophagy; Endothelial cells
• ISSN: 1868-4483; 1868-601X
• DOI: 10.1007/s12975-022-01084-7

Ischemic-reperfusion injury limits the time window of recanalization therapy in cerebral acute ischemic stroke (AIS). Brain vessel endothelial cells (BVECs) form the first layer of the blood–brain barrier (BBB) and are thus the first sufferer of ischemic-reperfusion disorder. The current study demonstrates that melatonin can reduce infarct volume, alleviate brain edema, ameliorate neurological deficits, and protect BBB integrity in prolonged-stroke mice. Here, we demonstrate that endoplasmic reticulum (ER)–associated injury contributes to BVEC death in the dural phase of reperfusion after prolonged ischemia. When encountering ischemia, ER stress arises, specifically activating PERK-EIF2α signaling and the subsequent programmed cell death. Prolonged ischemia leads stress granules (SGs) to be refractory, which remain unresolved and accumulate in ER during recanalization. During reperfusion, refractory SGs activate PKR-EIF2α and further exacerbate BVEC injury. We report that melatonin treatment downregulates ER stress in the ischemic period and enhances dissociation of the refractory SGs during reperfusion, thus offering dual-phase protection to BVECs in prolonged cerebral stroke. Mechanistically, melatonin enhances autophagy in BVECs, which preserves ER function and resolves refractory SGs. We, therefore, propose that melatonin is a potential treatment to extend the time window of delayed recanalization therapy in AIS.